Steve Tablak - Jun 1, 2022 Form 4 Insider Report for Lucira Health, Inc. (LHDXQ)

Role
Director
Signature
/s/ Dan George, Attorney-in-Fact for Steve Tablak
Stock symbol
LHDXQ
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:46 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LHDXQ Stock Option (right to buy) Award $0 +59.5K $0.00 59.5K Jun 1, 2022 Common Stock 59.5K $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting.